Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing dolutegravir (Tivicay®, Triumeq®, Juluca®): neural tube defects in babies whose mothers became pregnant while taking dolutegravir
2018.06.04
Active substance: dolutegravir
There are reports from an observational study on neural tube defects in babies, whose mothers became pregnant while taking dolutegravir.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN